Central Garden & Pet Co (NASDAQ: CENTA): How Much Is It Worth And What Should Investors Do?
During the last session, Central Garden & Pet Co (NASDAQ:CENTA)’s traded shares were 0.72 million, with the beta value of the company hitting 0.68. At
During the last session, Central Garden & Pet Co (NASDAQ:CENTA)’s traded shares were 0.72 million, with the beta value of the company hitting 0.68. At
During the last session, Inozyme Pharma Inc (NASDAQ:INZY)’s traded shares were 0.77 million, with the beta value of the company hitting 2.29. At the end
During the last session, GBank Financial Holdings Inc (NASDAQ:GBFH)’s traded shares were 0.88 million, with the beta value of the company hitting -0.20. At the
During the last session, Patria Investments Ltd (NASDAQ:PAX)’s traded shares were 0.76 million, with the beta value of the company hitting 0.67. At the end
During the last session, Popular Inc (NASDAQ:BPOP)’s traded shares were 0.82 million, with the beta value of the company hitting 0.65. At the end of
During the last session, Fresenius Medical Care AG ADR (NYSE:FMS)’s traded shares were 0.87 million, with the beta value of the company hitting 0.86. At
During the last session, Helen of Troy Ltd (NASDAQ:HELE)’s traded shares were 0.85 million, with the beta value of the company hitting 0.86. At the
During the last session, Kulicke & Soffa Industries, Inc (NASDAQ:KLIC)’s traded shares were 0.74 million, with the beta value of the company hitting 1.55. At
During the last session, Intchains Group Ltd ADR (NASDAQ:ICG)’s traded shares were 0.68 million, with the beta value of the company hitting 1.90. At the
During the last session, Bicara Therapeutics Inc (NASDAQ:BCAX)’s traded shares were 0.58 million. At the end of the trading day, the stock’s price was $9.32,
© 2024, Powered by Smart TechOne